跳至主要内容
临床试验/CTRI/2025/01/079756
CTRI/2025/01/079756尚未招募不适用

Amikacin Antibiotic prophylaxis in patient with perforation peritonitis :A Randomized Controlled Trial

Jawaharlal Institute of Postgraduate Medical Education and Research1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
130
试验地点
1
主要终点
To compare incidence of superficial deep organ space infection in patient receiving amikacin in addition to the standard ceftriaxone and metronidazole with that of patient receiving only the standard protocol following laparotomy for perforation peritonitis

研究概览

简要总结

Surgical site infections encompass a range of superficial to deep wound infections that can occur following an operative procedure. Surgical site infections are preventable complication, responsible for substantial financial burden to health services that can result in poorer patient outcomes,increased mortality, morbidity and reoperation rates.purpose of this study is to explore the usefulness of an antibiotic (injection amikacin) in reducing the occurrence of infections at the site of surgery when used in patient undergoing surgery for perforation peritonitis.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 未提供

排除标准

  • Renal failure Immunosuppressed.

结局指标

主要结局

To compare incidence of superficial deep organ space infection in patient receiving amikacin in addition to the standard ceftriaxone and metronidazole with that of patient receiving only the standard protocol following laparotomy for perforation peritonitis

时间窗: 4 weeks

次要结局

  • Surgical site infection, wound dehiscence, readmission, reintervention(4 weeks)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Subhash Mishra

JIPMER

研究点 (1)

Loading locations...

相似试验